Antitumor Agents. 282. 2′-(R)-O-Acetylglaucarubinone, a Quassinoid fromOdyendyea gabonensisAs a Potential Anti-Breast and Anti-Ovarian Cancer Agent

Authors:
  • YUYoshihide Usami
    Yoshihide Usami
  • JLJing-Yu Lang
    Jing-Yu Lang
  • YKYoon Kim
    Yoon Kim
  • CLChin-Yu Lai
    Chin-Yu Lai
  • MGMasuo Goto
    Masuo Goto
  • NSNobuko Sakurai
    Nobuko Sakurai
  • MTMasahiko Taniguchi
    Masahiko Taniguchi
  • TAToshiyuki Akiyama
    Toshiyuki Akiyama
  • SMSusan L. Morris-Natschke
    Susan L. Morris-Natschke
  • KBKenneth F. Bastow
    Kenneth F. Bastow
  • GCGordon Cragg
    Gordon Cragg

Abstract
A new quassinoid, designated 2′-(R)-O-acetylglaucarubinone (1), and seven known quassinoids (2−8) were isolated, using bioactivity-guided separation, from the bark of Odyendyea gabonensis (Pierre) Engler [syn. Quassia gabonensis Pierre]. The structure of 1 was determined by spectroscopic analysis and by semisynthesis from glaucarubolone. Complete 1H and 13C NMR assignments of compounds 1−8 were also established from detailed analysis of two-dimensional NMR spectra, and the reported configurations in odyendene (7) and odyendane (8) were corrected. Compound 1 showed potent cytotoxicity against multiple cancer cell lines. Further investigation using various types of breast and ovarian cancer cell lines suggested that 1 does not target the estrogen receptor or progesterone receptor. When tested against mammary epithelial proliferation in vivo using a Brca1/p53-deficient mice model, 1 also caused significant reduction in mammary duct branching.

This publication has 24 references indexed in Scilit: